65 related articles for article (PubMed ID: 2128268)
1. Mutagenicity studies on dihydroergocristine.
Dubini F; Bignami P; Zanotti A; Coppi G
Drugs Exp Clin Res; 1990; 16(6):255-61. PubMed ID: 2128268
[TBL] [Abstract][Full Text] [Related]
2. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
3. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
Irwin RD
Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
[TBL] [Abstract][Full Text] [Related]
4. Genotoxicity assessment of two hypergolic energetic propellant compounds.
Reddy G; Song J; Mecchi MS; Johnson MS
Mutat Res; 2010 Jul; 700(1-2):26-31. PubMed ID: 20417306
[TBL] [Abstract][Full Text] [Related]
5. NTP technical report on toxicity studies of urethane in drinking water and urethane in 5% ethanol administered to F344/N rats and B6C3F1 mice.
Chan PC
Toxic Rep Ser; 1996 Mar; (52):1-91, A1-9, B1-9 passim. PubMed ID: 11803705
[TBL] [Abstract][Full Text] [Related]
6. Mutagenicity studies of muroctasin.
Shimada H; Hattori C; Sato T
Arzneimittelforschung; 1988 Jul; 38(7A):1031-3. PubMed ID: 3056424
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the mutagenicity of a-dihydroergocryptine in vitro and in vivo.
Adams K; Allen JA; Brooker PC; Jones E; Proudlock RJ; Mailland F; Coppi G
Arzneimittelforschung; 1993 Dec; 43(12):1253-7. PubMed ID: 8141809
[TBL] [Abstract][Full Text] [Related]
8. [Genotoxicity studies of cefmatilen hydrochloride hydrate (S-1090)].
Kondo K; Takase S; Nishimoto Y; Miyajima H; Shiratori O; Miyake Y
J Toxicol Sci; 2001 May; 26 Suppl 1():243-54. PubMed ID: 11400316
[TBL] [Abstract][Full Text] [Related]
9. Absence of mutagenicity of acid pyrogallol-containing hair gels.
Mazzei JL; da Silva DN; Oliveira V; Hosomi RZ; do Val RR; Pestana CB; Felzenszwalb I
Food Chem Toxicol; 2007 Apr; 45(4):643-8. PubMed ID: 17140719
[TBL] [Abstract][Full Text] [Related]
10. Bovine bladder urothelial cell activation of carcinogens to metabolites mutagenic to Chinese hamster V79 cells and Salmonella typhimurium.
Oglesby LA; Hix C; Snow L; MacNair P; Seig M; Langenbach R
Cancer Res; 1983 Nov; 43(11):5194-9. PubMed ID: 6352016
[TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
12. Mutagenicity studies on thymomodulin.
Cantelli-Forti G; Hrelia P; Scotti M; Scornavacche V; Prada M
Arzneimittelforschung; 1987 Nov; 37(11):1269-73. PubMed ID: 3326604
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the mutagenicity of 1-hydrazino-4-(3,5-dimethyl-1-pyrazolyl) pyridazino[4,5-b]indole.
Lopez-de Cerain A; García E; Gullón A; Alvarez T; Losa MJ; Monge A
Arzneimittelforschung; 1994 Mar; 44(3):310-2. PubMed ID: 8192696
[TBL] [Abstract][Full Text] [Related]
14. Mutagenicity testing of the antiparasitic drug entizol (polfa) in the detection system of Salmonella typhimurium mutants.
Dobiás L
Mutat Res; 1980 Feb; 77(2):117-26. PubMed ID: 6990236
[TBL] [Abstract][Full Text] [Related]
15. DNA-damaging activity in vivo and bacterial mutagenicity of sixteen hydrazine derivatives as related quantitatively to their carcinogenicity.
Parodi S; De Flora S; Cavanna M; Pino A; Robbiano L; Bennicelli C; Brambilla G
Cancer Res; 1981 Apr; 41(4):1469-82. PubMed ID: 7214329
[TBL] [Abstract][Full Text] [Related]
16. Further examination of the effects of nitrosylation on Alternaria alternata mycotoxin mutagenicity in vitro.
Schrader TJ; Cherry W; Soper K; Langlois I
Mutat Res; 2006 Jul; 606(1-2):61-71. PubMed ID: 16698312
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity considerations and in vitro approaches to assess the genotoxicity of 19 methane-, benzene- and toluenesulfonic acid esters.
Glowienke S; Frieauff W; Allmendinger T; Martus HJ; Suter W; Mueller L
Mutat Res; 2005 Mar; 581(1-2):23-34. PubMed ID: 15725602
[TBL] [Abstract][Full Text] [Related]
18. In vitro genotoxicity of para-phenylenediamine and its N-monoacetyl or N,N'-diacetyl metabolites.
Garrigue JL; Ballantyne M; Kumaravel T; Lloyd M; Nohynek GJ; Kirkland D; Toutain H
Mutat Res; 2006 Sep; 608(1):58-71. PubMed ID: 16807077
[TBL] [Abstract][Full Text] [Related]
19. [Dihydroergocristine. A review of pharmacology and toxicology].
Coppi G
Arzneimittelforschung; 1992 Nov; 42(11A):1381-90. PubMed ID: 1492857
[TBL] [Abstract][Full Text] [Related]
20. Mutagenicity study of the new cognition-enhancing agent nefiracetam.
Shimada H; Hattori C; Tanaka N; Takayama S
Arzneimittelforschung; 1994 Feb; 44(2A):251-3. PubMed ID: 8018099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
